Trending News
News
News
MarcoPolo Pharmaceuticals Announces a Positive Phase II-III Study in Partial Seizure Patients
Double-blind, placebo-controlled clinical study to evaluate the efficacy, safety and tolerability of VLB-01.
News
Sepsis Study Comparing Three Treatment Methods Shows Same Survival Rate
NIH-funded clinical trial tested specific protocols against usual high-level care.
News
Pioneering Human Protein Atlas Project Achieves a Major Milestone
Project leverages Luminex's xMAP® technology for biobank profiling research.
News
Natera Announces Launch of Panorama™ NIPT in Portugal and Thailand
Company announces two new partnerships to launch Panorama™ outside of the US.
News
MIT Chemists Devise Novel Way to Manufacture Peptide Drugs
New, fast synthetic method enables manufacture of peptides in hours, which could boost drug development.
News
UCL’s Novel Approach to Research in Biologically-Relevant Models
Cellectricon and UCL unite to present a webinar, March 27, 11am-12pm EDT.
News
CiToxLAB Appoints John C. Kapeghian as Senior Director of Toxicology
This appointment makes the Montreal site attractive to North American clients and boosts CiToxLAB’s expertise in preclinical development and regulatory affairs.
News
Scientists Slow Development of Alzheimer's Cell-Killing Plaques
Researchers have learned how to fix a cellular structure called the Golgi that becomes fragmented in Alzheimer's patients.
News
Bright Future for Protein Nanoprobes
Berkeley Lab researchers discover new rules for single-particle imaging with light-emitting nanocrystals.
News
Atopix Announces Positive Phase IIb Results for Once Daily OC459 in Asthma
Company has announced the results at the AAAAI Annual Meeting, USA on March 1st.
Advertisement